CDTX vs SHOP · rev $1.3M vs P/E 107, rev $11.56B
Cidara Therapeutics Inc (CDTX) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported SHOP revenue for 2025-12-31 was $11.56B. Net income was $1.23B. Revenue was up 30.1% from 2024-12-31 to 2025-12-31. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
CDTX currently screens at market cap $6.96B. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the CDTX and SHOP stock pages for the full models.
Not investment advice.